Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention (SORT OUT XII)
Randomized Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention in an All Comer Population (The SORT OUT XII Trial)
Sponsor: Odense University Hospital
A NA clinical study on Coronary Artery Disease and Ischemia, Myocardial, this trial is actively recruiting participants. The trial is conducted by Odense University Hospital and has accumulated 2 data snapshots since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
2 versions recorded-
Jan 2025 — Present [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2024 — Jan 2025 [monthly]
Not Yet Recruiting NA
First recorded
Nov 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Odense University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .